Its active ingredient, semaglutide, belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists
The most common side effects reported in studies include: abdominal pain diarrhea nausea and vomiting decreased appetite (particularly with the tablet form of semaglutide) Its important to call a doctor immediately if you experience any severe side effects from semaglutide
Curr Anesthesiol Rep 14 , 152160 (2024)
AJ has served as a consultant and is on Speakers Bureaus for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Abbott, Novo Nordisk, Medtronic, and Sanofi
/ * 1 : 1 (GHK-Cu / , -500, -157) 70 , Peptide GLOW (GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg) for Injection, Apex Biopharma, 1 vial * 70 mg Apex Biopharma : ApBi-6102 GHK-Cu / + -500 + -157 70 57 15 052